Economic analyses of human genetics services: a systematic review. - Wikidata - awgldk - TriplyDB

Economic analyses of human genetics services: a systematic review.

Economic analyses of human genetics services: a systematic review.

http://www.wikidata.org/entity/Q36296074

about

Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence.Concepts of 'personalization' in personalized medicine: implications for economic evaluation.Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis.Personal utility and genomic information: look before you leap Translating genomic biomarkers into clinically useful diagnostics.Genomic Medicine: 'grand challenges' in the translation of genomics to human health.Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.Transforming the practice of medicine using genomics Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.The economic value of personalized medicine tests: what we know and what we need to know.Cost-effectiveness analysis in pharmacogenomics.A review of economic evaluations of genetic testing services and interventions (2004-2009).Genetic testing in the European Union: does economic evaluation matter?The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence.Is individualized medicine more cost-effective? A systematic review.Economics of stratified medicine in rheumatoid arthritis.Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia.Valuing the economic benefits of complex interventions: when maximising health is not sufficient.Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Precision Medicine: From Science To Value.Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions

P2860

Q22330767-7E611D00-AB47-4078-877F-568C1EE73B31 Q27324818-D957C01B-D5CB-4FF2-8314-5484BDFCA732 Q35024433-8ED94DD6-A3DE-4B83-B034-91ACA09C0A50 Q35575935-63C3CFF7-E5CC-411C-B84F-EDC580F8250E Q35751507-5BB49BAA-5B61-490D-9AC1-18A99A21D351 Q36158668-744601CD-0BF1-47DB-BAEA-06B708DEC923 Q36411676-2ECE9CA6-F41E-45B6-B5C8-A21A92AD117F Q37177256-EDBC9462-6985-4013-B2F1-7C4FE9FBECCC Q37315305-9D87CB5E-2032-413D-84A5-ED0CD3070E3D Q37430406-86208C0C-E939-43FD-A59A-6DE9F9849C94 Q37507366-BCA58F82-9997-482B-95BF-3777FB666402 Q37629385-7287A6F5-3BC4-4D3D-8DCE-04ACA72FBB7D Q37736459-07119DB7-07C0-4BD5-8A0B-2A500D99CDF1 Q37832922-11780503-95E2-4C5A-9522-35F45147CD14 Q37877618-7B935C26-2F71-458C-9CB6-CAB43B099515 Q38153808-58CCBAB8-1363-4F6C-B09B-77BB42ED5F3F Q38191496-C5C53F15-3A28-4237-98D2-E9309A9BF533 Q38264743-80F235D1-A245-4459-86FF-571B5FBE8CCB Q45130977-F5AEB074-EE69-4C39-B79F-D7BE179C0A27 Q46601983-B1FF3E8A-23C8-4937-AEAF-1455E0D16406 Q50091589-7C75714E-CE78-4E27-B2AC-25CA36E8B334 Q55072280-3E21D3B6-ED9C-4C28-A544-28AD7187551E Q57697360-3955C0C7-4143-4D57-BF59-1B8A4BD66490

P2860

Economic analyses of human genetics services: a systematic review.

http://www.wikidata.org/entity/Q36296074

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Economic analyses of human genetics services: a systematic review.

@ast

Economic analyses of human genetics services: a systematic review.

@en

type

label

Economic analyses of human genetics services: a systematic review.

@ast

Economic analyses of human genetics services: a systematic review.

@en

prefLabel

Economic analyses of human genetics services: a systematic review.

@ast

Economic analyses of human genetics services: a systematic review.

@en

P1433

Q36296074-FDF30564-F17A-4C4F-A386-E4BF4E5768DB

P1476

Q36296074-FF8E3389-E559-461D-8B0F-B2C95FE7C272

P2093

Q36296074-338E5F30-7B08-427E-9994-1B4241A950C3

Q36296074-8FBEAFA6-7817-42FD-B0BF-5D8DD433A181

Q36296074-A935BDE7-E2BB-428A-8742-9BBB46171244

Q36296074-C4F7CC75-50BF-4A2F-810D-6F62BAADCD89

P2860

Q36296074-02B1E4C6-869B-4DDD-973C-10CAB03C3FEC

Q36296074-050621C5-EF81-4DF9-A794-02E016C7A2A7

Q36296074-0A0493D9-3229-4E65-A7BB-EFE37F96A33E

Q36296074-19019673-D539-4C57-A36D-655474F7CE3C

Q36296074-46E54674-EAF1-4272-92E9-B543372915B8

Q36296074-53782EB0-CDA8-4283-9D7E-757F352FD651

Q36296074-638515D3-8A0A-47F4-9339-CA2403DE8461

Q36296074-768CD381-5D5E-4763-82E9-A85D605B2D62

Q36296074-7E844F49-77D1-4173-9E40-BE14A4879EA9

Q36296074-8CD6F315-3E23-4A1B-9760-BA472F82796D

P2888

Q36296074-D12E2664-86A6-4F6D-98B5-261C5C354DA3

P304

Q36296074-36ACF7EA-687F-4711-A180-161FC88D096A

P31

Q36296074-9B960B81-3D44-4F4E-B803-E02E81651D94

P356

Q36296074-B66810E9-7CA9-4F6C-862F-D9199308845F

P407

Q36296074-033491B5-1F06-4F72-9090-18DB1F5F14C7

P433

Q36296074-06BF2832-8445-4FDF-BB02-063CD65402B3

P478

Q36296074-D256B8EA-FD4A-462B-9EFC-A138BBC012FC

P577

Q36296074-55E8E272-4F92-454D-9FA6-4F4386DEE845

P6179

Q36296074-F46D65BA-17F6-41AD-B31F-D5B16BADB096

P698

Q36296074-B517230A-8C40-4B09-8F74-63D7D813599C

P356

01.GIM.0000182467.79495.E2

P1433

Genetics in Medicine

P1476

Economic analyses of human genetics services: a systematic review.

@en

P2093

David L Veenstra

http://www.w3.org/2001/XMLSchema#string

Josh J Carlson

http://www.w3.org/2001/XMLSchema#string

Nora Beidler Henrikson

http://www.w3.org/2001/XMLSchema#string

Scott D Ramsey

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.

Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.

Prenatal screening for cystic fibrosis carriers: an economic evaluation

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis.

The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal.

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions.

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

Will genetic testing alter the management of disease caused by infectious agents? A cost-effectiveness analysis of gene-testing strategies for prevention of rheumatic Fever.

P2888

01.gim.0000182467.79495.e2

P304

519-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.GIM.0000182467.79495.E2

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027549393

http://www.w3.org/2001/XMLSchema#string

P698

16247290

http://www.w3.org/2001/XMLSchema#string